AGE-RAGE in multiple sclerosis brain.

Abstract

This pilot study used immunohistochemical techniques to investigate the advanced glycation end-product (AGE) Nepsilon-(carboxymethyl)lysine (CML) and its receptor (RAGE) in the brains of multiple sclerosis (MS) patients, comparing them with the brains of patients with Alzheimer's disease (AD) (positive controls) and with age-matched control subjects (negative controls). Postmortem slides derived from the hippocampi of MS patients, AD patients, and controls were stained with monoclonal antibodies for CML and human RAGE. Results showed increased AGE and RAGE immunostaining in the hippocampi of MS patients, similar to AD patients.

DOI: 10.3109/08820139.2010.532267
02040201520162017
Citations per Year

Citation Velocity: 7

Averaging 7 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Sternberg2011AGERAGEIM, title={AGE-RAGE in multiple sclerosis brain.}, author={Zohara Z Sternberg and Peter Ostrow and Mary M. Vaughan and Trevor Chichelli and Frederick E. Munschauer}, journal={Immunological investigations}, year={2011}, volume={40 2}, pages={197-205} }